Inventor · disambiguated record
Paul A. Sprengeler
Also filed as: SPRENGELER PAUL · SPRENGELER PAUL A
33 granted patents·11 pending applications·602 citations·filing 1991–2023
97Inventor score
Files withEFFECTOR THERAPEUTICS INC25UNIV PENNSYLVANIA14SGX PHARMACEUTICALS INC2ARNOLD WILLIAM D1AXYS PHARM INC1
Top patents by PatentIndex Score
44 records- 0198US7626021B2Fused ring heterocycle kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2007·Granted Dec 1, 2009·179 cites·11 claims
- 0295US9382248B2Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2015·Granted Jul 5, 2016·14 cites·25 claims
- 0394US9669031B2MNK inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2016·Granted Jun 6, 2017·12 cites·20 claims
- 0494US8158647B2Substituted pyrrolopyridines and pyrazolopyridines as kinase modulatorsBLANEY JEFFREY M·Filed 2008·Granted Apr 17, 2012·93 cites·35 claims
- 0589US9814718B2MNK inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·5 cites·20 claims
- 0688US11083727B2Piperidine-substituted Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Granted Aug 10, 2021·2 cites·3 claims
- 0788US10577378B2EIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Granted Mar 3, 2020·6 cites·14 claims
- 0888US9957277B2eIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2016·Granted May 1, 2018·6 cites·14 claims
- 0987US7709645B2Pyrrolo-pyridine kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2007·Granted May 4, 2010·7 cites·28 claims
- 1085US11130757B2Crystalline forms of MNK inhibitorsEFFECTOR THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·2 cites·10 claims
- 1185US10000487B2Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancersEFFECTOR THERAPEUTICS INC·Filed 2016·Granted Jun 19, 2018·5 cites·5 claims
- 1283US11440917B2EIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2020·Granted Sep 13, 2022·1 cites·19 claims
- 1382US2023295179A1Eif4a-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1481US5811512ANon-peptide peptidomimetics and related cyclic hexapeptidesUNIV PENNSYLVANIA·Filed 1996·Granted Sep 22, 1998·38 cites·15 claims
- 1581US5552534ANon-Peptide peptidomimeticsUNIV PENNSYLVANIA·Filed 1993·Granted Sep 3, 1996·62 cites·16 claims
- 1680US10112955B2Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2EFFECTOR THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·2 cites·19 claims
- 1780US5550251AAlicyclic peptidomimeticsUNIV PENNSYLVANIA·Filed 1994·Granted Aug 27, 1996·20 cites·10 claims
- 1879US11286268B1EIF4E-inhibiting compounds and methodsEFFECTOR THERAPEUTICS INC·Filed 2020·Granted Mar 29, 2022·1 cites·28 claims
- 1979US5817879AAlicyclic peptidomimeticsUNIV PENNSYLVANIA·Filed 1996·Granted Oct 6, 1998·22 cites·16 claims
- 2078US10793551B2Benzimidazole-indole inhibitors of Mnk1 and Mnk2EFFECTOR THERAPEUTICS INC·Filed 2018·Granted Oct 6, 2020·2 cites·16 claims
- 2178US5886046ADicarbonyl-containing compoundsUNIV PENNSYLVANIA·Filed 1996·Granted Mar 23, 1999·19 cites·14 claims
- 2277US2023071483A1Eif4a-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2375US2021338673A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2474US11878015B2Piperidine-substituted Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·9 claims
- 2571US6197963B1Non-peptide peptidomimeticsUNIV PENNSYLVANIA·Filed 1998·Granted Mar 6, 2001·37 cites·15 claims
- 2670US11952375B2Crystalline forms of Mnk inhibitorsEFFECTOR THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·0 cites·6 claims
- 2766US2019209560A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2864US5514814APyrrolinone-based compoundsUNIV PENNSYLVANIA·Filed 1994·Granted May 7, 1996·8 cites·9 claims
- 2963US2018085368A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3063US2023108594A1Eif4e-inhibiting compounds and methodsEFFECTOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3162US11014926B2Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2EFFECTOR THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·0 cites·17 claims
- 3262US8268994B2Fused ring heterocycle kinase modulatorsARNOLD WILLIAM D·Filed 2009·Granted Sep 18, 2012·0 cites·37 claims
- 3362US6455570B1Polypyrrolinone based inhibitors of matrix metalloproteasesUNIV PENNSYLVANIA·Filed 2001·Granted Sep 24, 2002·2 cites·9 claims
- 3462US5489692APyrrolinone-based compoundsUNIV PENNSYLVANIA·Filed 1993·Granted Feb 6, 1996·8 cites·13 claims
- 3559US6030942APeptides peptide analogs peptidomimetics and other small molecules useful for inhibiting the activity of ribonucleotide reductaseUNIV PENNSYLVANIA·Filed 1998·Granted Feb 29, 2000·18 cites·7 claims
- 3658US5770732APyrrolinone-based peptidomimeticsUNIV PENNSYLVANIA·Filed 1994·Granted Jun 23, 1998·14 cites·23 claims
- 3757US6034247AOxazolidinones and methods for the synthesis and use of sameUNIV PENNSYLVANIA·Filed 1997·Granted Mar 7, 2000·8 cites·5 claims
- 3857US2025243221A1Covalent modifiers of eif4e inhibiting compoundsEFFECTOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3956US2019152988A1Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of mnk1 and mnk2EFFECTOR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4055US2018228803A1Piperidine-Substituted Mnk Inhibitors and Methods Related TheretoEFFECTOR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4147US5250564AAromatic peptidomimeticsUNIV PENNSYLVANIA·Filed 1991·Granted Oct 5, 1993·3 cites·12 claims
- 4246US2017121339A1Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit mnk1 and mnk2EFFECTOR THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4341US5519060ASulfonamide-based compositions and methodsUNIV PENNSYLVANIA·Filed 1995·Granted May 21, 1996·6 cites·17 claims
- 4437US2005026929A1Novel phenyl derivatives as inducers of apoptosisAXYS PHARM INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul A. Sprengeler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →